MARKET WIREMoomoo • 1d ago
Milestone Scientific(MLSS) Stock Options Chain | Quotes & NewsMoomoo report covering Milestone Scientific Inc. (MLSS) market action, institutional positioning, and fundamental catalysts.
Why MLSS Stock dropped -3.30% Today — RQD Quant Desk Flash
$0.30 -3.30% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $0.30
Milestone Scientific Inc. (MLSS) carries a Roarable Rating of D- (Sell) with 40/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
ROARABLE D- • RED ALERT
Cap $27.6M
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER
Click Any Pre-Computed AI Quant Specialist Briefing on MLSS Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is MLSS stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-03, Milestone Scientific Inc. (NYSE: MLSS) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 40/100 at a spot price of $0.30 (-3.30% 1D, market cap $27.6M). Pillar breakdown: Fundamental Cash Engine 4/20, Institutional 13F & Options Flow 12/20, SEC Balance-Sheet Forensics 13/20, FRED Macro Regime Fit 4/20, and Executive Insider Alignment 7/20. Across 1015 tracked Health Care issuers, MLSS ranks #467 in composite RQD confidence.
✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does MLSS compare to LFWD and HSCS in the Health Care sector?
▼
Within the Health Care sector (Industrial Specialties), MLSS carries a Roarable D- (40/100 RQD), trailing P/E of 5.0x, gross margin of 71.4%, and ROIC of -35.0%. By comparison, LFWD (Lifeward Ltd.) holds a E grade (32/100 RQD, P/E N/A, ROIC -35.0%, cap $16.9M) and HSCS (HeartSciences Inc.) posts a D- grade (38/100 RQD, P/E N/A, ROIC -35.0%, cap $16.0M). Among the 5-stock peer group, MLSS leads on earnings multiple (5.0x) while MLSS leads on capital efficiency (-35.0% ROIC).
✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for MLSS?
▼
Per MLSS's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000855683), Milestone Scientific Inc. generated $9.0M in revenue (+4.0% YoY), $5.7M in net income, and -$2.9M in free cash flow against $7.8M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.
✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $0.30 (-0.78%)🧬 Dilution Drag (+1.36% YoY Shares)⚙️ Cash Engine: 4/20 (E) • 0% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record Warning: Scores below 50 (40/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows (-7.4% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →RQD QUANT TACHOMETERRED ALERT • D-
2-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw D- · Rk D-
Each axis scored 0–20
12M PRICE TARGET CONE-6.7% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for MLSS)Realized 20D OHLCV Swing Band: ±12.5%
Deterministic 5-Pillar Attribution (40/100 Composite)
🔍 WHY MLSS SCORES 40/100 (D-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: SEC 10-K Forensic Risk+13/20 pts (33% of score)
Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 4/9
▲ #2 Bullish Driver: Whale & Options Positioning+12/20 pts (30% of score)
20D Institutional Volume Accumulation (±12.5% realized swing band)
▼ #1 Drag / Risk Factor: Macro Regime Fit4/20 pts (-16 pt drag)
Macro rate sensitivity & RSI-14 (35.4) create a -16 pt regime headwind
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade D$0.34+0% Next Q
48
Q2 (-2Q)Grade D$0.34-11.8% Next Q
45
Q3 (-1Q)Grade D$0.30+0% Next Q
43
CurrentGrade D-$0.30-7.4% Hist 90D α
40
Trajectory: D (48) → D- (40)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER
⚔️ Adversarial Opposing Case: What Could Spark a MLSS Turnaround Squeeze
While MLSS currently carries a cautious 40/100 (D-) rating due to Macro Regime Fit (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
🚀 Contrarian Squeeze Trigger #1
Established market leader in Health Care with deep daily trading liquidity.
🚀 Contrarian Squeeze Trigger #2
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($0.39) and Max Pain ($0.32) forces dealer call-delta covering toward $0.61.
🚀 Contrarian Squeeze Trigger #3
Forensic Repair Trigger: Halting share dilution (Dilution Drag (+1.36% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
🎲 LIVE PREDICTION MARKET ODDS TIED TO $MLSS• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “MLSS Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why MLSS Stock dropped -3.30% Today — RQD Quant Desk Flash
Milestone Scientific Inc. (MLSS) dropped -3.30% to $0.30, trading at 22% of its 52-week range ($0.22 – $0.58). Stretched risk/reward at 5x P/E (-35% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 22% of its 52-week range ($0.22 – $0.58) with RSI-14 at 35.4 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±12.5% around $0.30 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable D- (Sell) backed by 71.4% gross margin and $0 annual free cash flow.
Live MLSS Headlines & Catalysts
MARKET WIREYahoo Finance UK • 1d ago
Milestone Scientific, Inc. (MLSS) Seasonal returns chartYahoo Finance UK report covering Milestone Scientific Inc. (MLSS) market action, institutional positioning, and fundamental catalysts.
MARKET WIRETradingView • 1d ago
Milestone Scientific, Inc. Estimates – AMEX:MLSSTradingView report covering Milestone Scientific Inc. (MLSS) market action, institutional positioning, and fundamental catalysts.
MARKET WIREStock Titan • 1d ago
Reaching 2% of estimated U.S. epidural procedures could mean about $33 million a year in potential single-use sales.Stock Titan report covering Milestone Scientific Inc. (MLSS) market action, institutional positioning, and fundamental catalysts.
CATALYSTWBOC TV • 1d ago
Milestone Scientific Provides Major Commercial Growth Update as CompuFlo® Expands Across 30 Million+ Annual Global Epidural ProceduresWBOC TV report covering Milestone Scientific Inc. (MLSS) market action, institutional positioning, and fundamental catalysts.
MARKET WIREBenzinga • 1d ago
12 Health Care Stocks Moving In Monday's After-Market Session - Flyte Aviation (AMEX:VJET), Option Care HBenzinga report covering Milestone Scientific Inc. (MLSS) market action, institutional positioning, and fundamental catalysts.
MARKET WIRETradingKey • 1d ago
Complete U.S. Stocks List: Prices, Performance and Key DataTradingKey report covering Milestone Scientific Inc. (MLSS) market action, institutional positioning, and fundamental catalysts.
MARKET WIREYahoo Finance UK • 1d ago
Retractable Technologies, Inc. (RVP) Seasonal returns chartYahoo Finance UK report covering Milestone Scientific Inc. (MLSS) market action, institutional positioning, and fundamental catalysts.
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring MLSS)
- ✓Walkthrough of MLSS's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
MLSS // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -14.29%🛡️ HOLDING TREND SUPPORT
2026-11-03O $0.31H $0.31L $0.30C $0.30VOL 42.0K
RES: $0.67SUP: $0.28SMA50: $0.39SMA200: $0.35
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
MLSS Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle
-14.0%/yr Implied 5Y Growth
vs. +4.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger
No active Ellis Vennor swing setup published on MLSS today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for MLSS. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for MLSS today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (MLSS)
Health Care Rank #467 of 1015
⚔️ LFWD vs MLSS Full Matrix →
1. Head-to-Head Health Care Peer Comparison (MLSS vs. LFWD, HSCS, MYO, COCH)
Industry: Industrial Specialties (55 Tracked Issuers)Across 1015 tracked Health Care securities in the Roarable RQD universe, Milestone Scientific Inc. (MLSS) ranks #467 by composite RQD confidence (40/100, grade D-) and #806 by equity capitalization ($27.6M). Within this direct 5-issuer industry benchmark cohort, MLSS leads on earnings valuation at 5.0x trailing P/E, while MLSS leads on capital efficiency and profitability with -35.0% ROIC and 71.4% gross margin. MLSS currently leads its immediate peer cohort in composite quantitative strength at 40/100 (D-).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| MLSS
ACTIVE
Milestone Scientific Inc. | D- | 40/100 | 5.0x | 71.4% | -35.0% | -3.30% | $27.6M | Benchmark Subject |
| LFWD Lifeward Ltd. | E | 32/100 | — | 96.0% | -35.0% | +0.71% | $16.9M | /lfwd-vs-mlss → |
| HSCS HeartSciences Inc. | D- | 38/100 | — | 59.1% | -35.0% | -8.31% | $16.0M | /hscs-vs-mlss → |
| MYO Myomo Inc. | E | 31/100 | — | 65.7% | -35.0% | -4.61% | $49.1M | /myo-vs-mlss → |
| COCH Envoy Medical Inc. (Class A) | D- | 36/100 | — | -30.0% | -35.0% | +2.00% | $51.3M | /coch-vs-mlss → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0000855683 ↗In its most recent audited fiscal period (FY2025, filed 2025-12-31), Milestone Scientific Inc. (MLSS) reported GAAP revenue of $9.0M (+4.0% vs. FY2024 revenue of $8.6M , and -54.9% cumulative change since FY2023) , GAAP net income of $5.7M, operating cash flow of -$2.9M, and free cash flow of -$2.9M (-0.1% YoY). On the balance sheet, MLSS closed FY2025 with $7.8M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 4/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $9.0M | $5.7M | -$2.9M | -$2.9M | $7.8M | — |
| FY2024 (FY) | 2024-12-31 | $8.6M | $4.7M | -$2.9M | -$2.9M | $9.8M | — |
| FY2023 (FY) | 2023-12-31 | $19.9M | $6.9M | -$5.3M | -$5.3M | — | — |
3. MLSS Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs MLSS stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-03, Milestone Scientific Inc. (NYSE: MLSS) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 40/100 at a spot price of $0.30 (-3.30% 1D, market cap $27.6M). Pillar breakdown: Fundamental Cash Engine 4/20, Institutional 13F & Options Flow 12/20, SEC Balance-Sheet Forensics 13/20, FRED Macro Regime Fit 4/20, and Executive Insider Alignment 7/20. Across 1015 tracked Health Care issuers, MLSS ranks #467 in composite RQD confidence.
How does MLSS compare to LFWD and HSCS in the Health Care sector?
Within the Health Care sector (Industrial Specialties), MLSS carries a Roarable D- (40/100 RQD), trailing P/E of 5.0x, gross margin of 71.4%, and ROIC of -35.0%. By comparison, LFWD (Lifeward Ltd.) holds a E grade (32/100 RQD, P/E N/A, ROIC -35.0%, cap $16.9M) and HSCS (HeartSciences Inc.) posts a D- grade (38/100 RQD, P/E N/A, ROIC -35.0%, cap $16.0M). Among the 5-stock peer group, MLSS leads on earnings multiple (5.0x) while MLSS leads on capital efficiency (-35.0% ROIC).
What are the biggest fundamental strengths and SEC risk factors for MLSS?
Per MLSS's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000855683), Milestone Scientific Inc. generated $9.0M in revenue (+4.0% YoY), $5.7M in net income, and -$2.9M in free cash flow against $7.8M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.
Where is MLSS trading relative to its 50-day, 200-day, and 52-week technical levels?
MLSS last traded at $0.30 (-3.30% on volume of 41,985 shares), positioning the stock -23.08% below its 50-day simple moving average ($0.39) and -14.29% below its 200-day simple moving average ($0.35). Across its 52-week range of $0.22 to $0.58, MLSS sits at the 22.2% percentile with a 14-day RSI of 35.4 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($1.00 to $0.34).
ROARABLE RATING BRIEF • RQD 40/100 (D-)
✓ SEC XBRL & RQD VERIFIED
MLSS — Milestone Scientific Inc.: What the Facts Mean to a Prospective Investor
Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2025-12-31
1. Roarable Rating Brief: What This Means to a Prospective Investor
Milestone Scientific Inc. (MLSS) earns a live Roarable RQD composite score of 40/100, corresponding to a D- letter grade (Roarable Sell) at a spot price of $0.30 (-3.30% 1D, market capitalization $27.6M).
- Fundamental Cash Engine (4/20): Anchored by return on invested capital (ROIC) of -35.0%, gross margin of 71.4%, operating margin of -60.0%, and free cash flow yield of -10.27%.
- Whale 13F & Options Flow (12/20) + Insider Conviction (7/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
- Macro Regime Fit (4/20) + Forensic Balance Sheet (13/20): Incorporates a 1.00x equity beta, Altman Z-Score of N/A, Piotroski F-Score of 4/9, and Debt/Equity of N/A.
2. Business Model, Unit Margins & SEC Financial Trajectory
Milestone Scientific Inc. Is a NYSE-listed issuer classified in the Health Care sector and Industrial Specialties industry,. The company reported revenue of $9.0M for FY 2025 and $8.6M for FY 2024. Per the market data, gross margin is 71.4%.
In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), Milestone Scientific Inc. (MLSS) reported $9.0M in annual revenue (up from $8.6M in FY2024, +4.0% YoY) and $5.7M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($19.9M revenue, $6.9M net income) through FY2025, MLSS scaled operating cash flow to -$2.9M and free cash flow to -$2.9M, backed by $7.8M in total assets against $0 in total debt.
3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff
- 🐂 Primary Bull Case (D- • RQD 40/100): Established market leader in Health Care with deep daily trading liquidity. Free cash flow yield of -10.27% and institutional whale pillar of 12/20. With Fundamental Cash Engine at 4/20 and Institutional Whale Flow at 12/20, sustained execution supports upside toward the upper end of the $0.22 – $0.58 52-week range.
- 🐻 Primary Bear Case & Valuation Risk: Company executives have done more routine share selling than personal cash buying lately. Investors must weigh 5.0x trailing P/E against -60.0% operating margins and a 1.00x macro beta.
4. 2nd-Order Butterfly Ripples & Key Questions to Watch
— for upstream supplier dependencies, downstream customer concentration, or 2nd-order bottlenecks.
- Key Question #1: Can MLSS sustain or expand its -60.0% operating margin and -35.0% ROIC against Industrial Specialties peers over the next 4 quarters?
- Key Question #2: Following FY2025 revenue of $9.0M and free cash flow of -$2.9M, how will capital allocation balance growth reinvestment against $0 in total debt?
- Key Question #3: How sensitive is MLSS's 4.7x forward P/E multiple to Health Care capital spending cycles and macro interest-rate shifts (Beta 1.00x)?
MLSS Live News Feed, Press Releases & Catalyst Wire
Real-time company headlines, analyst actions, and sector developments for Milestone Scientific Inc. (MLSS) • Click "Debate This Headline" to argue it in the Roar Pit below
🟡 MARKET WIRE Moomoo • 1d ago
Milestone Scientific(MLSS) Stock Options Chain | Quotes & News Moomoo report covering Milestone Scientific Inc. (MLSS) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Yahoo Finance UK • 1d ago
Milestone Scientific, Inc. (MLSS) Seasonal returns chart Yahoo Finance UK report covering Milestone Scientific Inc. (MLSS) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE TradingView • 1d ago
Milestone Scientific, Inc. Estimates – AMEX:MLSS TradingView report covering Milestone Scientific Inc. (MLSS) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Stock Titan • 1d ago
Reaching 2% of estimated U.S. epidural procedures could mean about $33 million a year in potential single-use sales. Stock Titan report covering Milestone Scientific Inc. (MLSS) market action, institutional positioning, and fundamental catalysts.
🟢 CATALYST WBOC TV • 1d ago
Milestone Scientific Provides Major Commercial Growth Update as CompuFlo® Expands Across 30 Million+ Annual Global Epidural Procedures WBOC TV report covering Milestone Scientific Inc. (MLSS) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Benzinga • 1d ago
12 Health Care Stocks Moving In Monday's After-Market Session - Flyte Aviation (AMEX:VJET), Option Care H Benzinga report covering Milestone Scientific Inc. (MLSS) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE TradingKey • 1d ago
Complete U.S. Stocks List: Prices, Performance and Key Data TradingKey report covering Milestone Scientific Inc. (MLSS) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Yahoo Finance UK • 1d ago
Retractable Technologies, Inc. (RVP) Seasonal returns chart Yahoo Finance UK report covering Milestone Scientific Inc. (MLSS) market action, institutional positioning, and fundamental catalysts.
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE
3 Active Posts & Replies
MLSS Bull vs. Bear Conversation Board — What's Your Call at $0.30?
🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON MLSS 🐻 33% BEARISH CONVICTION
DE DeltaGamma_99 RQD DEBATE OPENER • Options Flow Specialist 🐂 BULLISH
🎯 Target: $0.38 (+26.7%)
📌 Pinned Debate Low headline valuation (P/E TTM of 5, Forward P/E of 4.7) combined with a GREEN-flagged CompuFlo® commercial growth catalyst across 30
Picked up a starter position in MLSS in my $100K Virtual Cash book at $0.30. Low headline valuation (P/E TTM of 5, Forward P/E of 4.7) combined with a GREEN-flagged CompuFlo® commercial growth catalyst across 30 million+ annual global epidural procedures.. Trading inside a $0.22–$0.58 52-week range with -10.27% FCF yield gives solid downside support if Industrial Specialties multiples expand this quarter.
VolSurface_Trader 🐂 BULL
@FadeTheHype Shorting a 12/20 institutional whale-flow stock at $0.30 is dangerous when funds are rotating into Health Care.
FA FadeTheHype RQD DEBATE OPENER • Contrarian Tape Reader 🐻 BEARISH
🎯 Target: $0.24 (-20.0%)
Spot @ $0.30 Negative ROIC of -35%, negative free cash flow in each reported year, and cash falling from $3.3M to $1.1M, with a -60% operating margi
Negative ROIC of -35%, negative free cash flow in each reported year, and cash falling from $3.3M to $1.1M, with a -60% operating margin that the data does not reconcile against positive net income.. Look at the math on MLSS: paying 5.0x trailing P/E for -35.0% ROIC and -60.0% operating margins leaves zero margin of safety if Industrial Specialties demand softens. I'd wait for a retest of $0.26 before getting long.